According to a market report by Lucintel, the future of the empty capsule market looks promising with opportunities in pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The global empty capsule market is expected to reach an estimated $4.1 billion by 2028 with a CAGR of 7.7% from 2023 to 2028. The major drivers for this market are growing demand for halal gelatin and vegetarian capsules, rising demand for nutraceutical ingredient based capsules, and growing need for empty capsules as the pharmaceutical industry flourishes.
In this market, gelatin and non-gelatin are the two product types of empty capsule used by various end use industries. Lucintel forecasts that gelatin capsules will remain the larger segment over the forecast period due to increasing demand for immediate-release capsules by manufacturers for production of medical products, such as antibiotics, inhalers, pain relievers, and dietary supplements.
Within this market, pharmaceutical industry is expected to remain the largest segment due to the growing prevalence of chronic diseases and technological advancement in capsule manufacturing.
North America will remain the largest region due to the presence of a well-developed and organized healthcare system, increasing government funding in healthcare, and rising geriatric population in the region.
Capsugel, ACG, Qualicaps, Suheung, CapsCanada, and Qingdao Yiqing are the major suppliers in the global empty capsule market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global empty capsule market by product type, functionality, therapeutic application, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Empty Capsule Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global empty capsule market by product type, functionality, therapeutic application, end use industry, and region, as follows:
Empty Capsule Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Gelatin Capsules
Porcine
Bovine
Bone Meal
Others
Non-Gelatin Capsules
Hydroxypropyl Methylcellulose (HPMC)
Pullulan and Starch Material
Empty Capsule Market by Functionality [Value ($B) Shipment Analysis from 2017 to 2028]:
Immediate-Release Capsules
Sustained-Release Capsules
Delayed-Release Capsules
Empty Capsule Market by Therapeutic Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Antibiotic & Antibacterial Drugs
Dietary Supplement
Antacid & Antiflatulent Preparation
Antianemic Preparation
Anti-inflammatory Drugs
Cardiovascular Therapy Drugs
Cough & Cold Drug Preparation
Others
Empty Capsule Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical Industry
Nutraceutical Industry
Cosmetic Industry
Research Laboratories
Empty Capsule Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the empty capsule market by product type (gelatin capsules and non-gelatin capsules), functionality (immediate-release capsules, sustained-release capsules, and delayed-release capsules), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drug preparations, and others), end use industry (pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?